Veterinary Medicines

Advocate 40 mg + 4 mg - Spot-on solution

Authorised

Moxidectin
Imidacloprid

Download as PDF

Product identification

Medicine name:

Advocate 40 mg + 4 mg - Spot-on solution

Active substance:

Moxidectin
Imidacloprid

Target species:

Cat
Ferret

Route of administration:

Spot-on use

Product details

Active substance and strength:

Moxidectin

Presentation_strength:4 mg Reference:Hse Index:0
Imidacloprid

Presentation_strength:40 mg Reference:Hse Index:1

Pharmaceutical form:

Spot-on solution

Anatomical therapeutic chemical veterinary (ATCvet) codes:

QP54AB52

Legal status of supply:

Veterinary medicinal product subject to veterinary prescription

Authorisation status:

Valid

Authorised in:

Available in:

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom (Northern Ireland)

Package description:

Packaging:Pipette (PP) with screw cap (PP), Package_size:12 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:9 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:2 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:1 pipette, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:42 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:6 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:21 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:4 pipettes, Content:0.4 ml
Packaging:Pipette (PP) with screw cap (PP), Package_size:3 pipettes, Content:0.4 ml

Additional information

Entitlement type:

Marketing Authorisation

Legal basis of product authorisation:

Complete application (stand-alone) - Council Directive 81/851/EEC

Marketing authorisation holder:

Elanco Animal Health GmbH

Marketing authorisation date:

2/04/2003

Manufacturing sites for batch release:

KVP Pharma + Veterinaer Produkte GmbH

Responsible authority:

European Commission

Authorisation number:

This information is not available for this product.

Date of authorisation status change:

14/06/2011

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Combined File of all Documents

English (PDF)

Published on: 3/04/2025

Other languages (24)

Bulgarian (PDF)

Published on: 3/04/2025

Croatian (PDF)

Published on: 3/04/2025

Czech (PDF)

Published on: 3/04/2025

Danish (PDF)

Published on: 3/04/2025

Dutch (PDF)

Published on: 3/04/2025

Estonian (PDF)

Published on: 3/04/2025

Finnish (PDF)

Published on: 3/04/2025

French (PDF)

Published on: 3/04/2025

German (PDF)

Published on: 3/04/2025

Greek (PDF)

Published on: 3/04/2025

Hungarian (PDF)

Published on: 3/04/2025

Icelandic (PDF)

Published on: 3/04/2025

Italian (PDF)

Published on: 3/04/2025

Latvian (PDF)

Published on: 3/04/2025

Lithuanian (PDF)

Published on: 3/04/2025

Maltese (PDF)

Published on: 3/04/2025

Norwegian (PDF)

Published on: 3/04/2025

Polish (PDF)

Published on: 3/04/2025

Portuguese (PDF)

Published on: 3/04/2025

Romanian (PDF)

Published on: 3/04/2025

Slovak (PDF)

Published on: 3/04/2025

Slovenian (PDF)

Published on: 3/04/2025

Spanish (PDF)

Published on: 3/04/2025

Swedish (PDF)

Published on: 3/04/2025

ema-puar-advocate-v-076-var-ii-0041-g-en.pdf

English (PDF)

Published on: 20/03/2023

ema-puar-advocate-v-076-var-ii-0022-en.pdf

English (PDF)

Published on: 20/03/2023

ema-puar-advocate-v-076-var-ii-0026-g-en.pdf

English (PDF)

Published on: 20/03/2023

ema-puar-advocate-v-076-par-en.pdf

English (PDF)

Published on: 20/03/2023

ema-puar-advocate-v-076-var-ii-0039-g-en.pdf

English (PDF)

Published on: 20/03/2023

ema-puar-advocate-v-000046-par-en.pdf

English (PDF)

Published on: 9/08/2022